Ubs Group Ag Vivos Therapeutics, Inc. Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$0.18 - $0.52 $1,666 - $4,813	9,257 New	9,257 $1,000
Q4 2022 Feb 08, 2023	BUY	$0.35 - $20.75 $3,202 - $189,841	9,149 Added 94.68%	18,812 $7,000
Q3 2022 Nov 10, 2022	BUY	$0.83 - $21.25 $6,183 - $158,312	7,450 Added 336.65%	9,663 $6,000
Q2 2022 Aug 10, 2022	BUY	$1.12 - $2.18 $2,478 - $4,824	2,213 New	2,213 $3,000
Q1 2022 May 16, 2022	SELL	$1.63 - $3.63 $27,845 - $62,011	-17,083 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.25 - $4.11 $31,923 - $58,312	14,188 Added 490.09%	17,083 $38,000
Q3 2021 Nov 15, 2021	BUY	$2.71 - $5.9 $1,504 - $3,274	555 Added 23.72%	2,895 $12,000
Q2 2021 Aug 13, 2021	BUY	$4.83 - $9.67 $1,072 - $2,146	222 Added 10.48%	2,340 $12,000
Q1 2021 May 12, 2021	BUY	$6.01 - $8.9 $12,729 - $18,850	2,118 New	2,118 $14,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $78.2M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.